Dean Investment Associates LLC trimmed its position in shares of Maximus, Inc. (NYSE:MMS - Free Report) by 34.0% in the 3rd quarter, according to the company in its most recent disclosure with the SEC. The fund owned 36,994 shares of the health services provider's stock after selling 19,095 shares during the quarter. Dean Investment Associates LLC owned about 0.06% of Maximus worth $3,446,000 at the end of the most recent reporting period.
A number of other institutional investors have also modified their holdings of the company. Inspire Advisors LLC grew its holdings in Maximus by 1.4% in the second quarter. Inspire Advisors LLC now owns 8,768 shares of the health services provider's stock worth $751,000 after purchasing an additional 121 shares during the last quarter. Wealth Enhancement Advisory Services LLC grew its stake in Maximus by 4.5% during the 2nd quarter. Wealth Enhancement Advisory Services LLC now owns 3,179 shares of the health services provider's stock worth $272,000 after buying an additional 136 shares during the last quarter. Petrus Trust Company LTA increased its position in Maximus by 2.7% during the 3rd quarter. Petrus Trust Company LTA now owns 7,084 shares of the health services provider's stock valued at $660,000 after buying an additional 185 shares in the last quarter. WR Wealth Planners LLC raised its stake in Maximus by 4.6% in the second quarter. WR Wealth Planners LLC now owns 4,525 shares of the health services provider's stock valued at $388,000 after buying an additional 198 shares during the last quarter. Finally, GAMMA Investing LLC boosted its holdings in Maximus by 224.5% in the second quarter. GAMMA Investing LLC now owns 344 shares of the health services provider's stock worth $29,000 after acquiring an additional 238 shares in the last quarter. 97.21% of the stock is currently owned by institutional investors.
Analyst Upgrades and Downgrades
Separately, StockNews.com downgraded shares of Maximus from a "buy" rating to a "hold" rating in a report on Thursday, November 28th.
Check Out Our Latest Stock Analysis on MMS
Insider Activity at Maximus
In related news, insider Michelle F. Link sold 1,363 shares of Maximus stock in a transaction that occurred on Tuesday, October 1st. The stock was sold at an average price of $92.56, for a total transaction of $126,159.28. Following the completion of the transaction, the insider now directly owns 6,567 shares in the company, valued at approximately $607,841.52. This trade represents a 17.19 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 1.40% of the stock is owned by insiders.
Maximus Stock Performance
Shares of NYSE MMS traded down $1.14 during mid-day trading on Friday, hitting $72.70. The stock had a trading volume of 655,672 shares, compared to its average volume of 1,196,237. The firm has a market cap of $4.38 billion, a PE ratio of 14.54 and a beta of 0.73. The company has a debt-to-equity ratio of 0.59, a quick ratio of 1.49 and a current ratio of 1.49. The company has a 50 day moving average of $84.71 and a two-hundred day moving average of $87.14. Maximus, Inc. has a twelve month low of $71.75 and a twelve month high of $93.97.
Maximus Dividend Announcement
The company also recently announced a quarterly dividend, which was paid on Saturday, November 30th. Investors of record on Friday, November 15th were issued a dividend of $0.30 per share. This represents a $1.20 dividend on an annualized basis and a dividend yield of 1.65%. The ex-dividend date of this dividend was Friday, November 15th. Maximus's dividend payout ratio (DPR) is 24.00%.
Maximus Profile
(
Free Report)
Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.
Read More
Before you consider Maximus, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Maximus wasn't on the list.
While Maximus currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link below to learn more about using beta to protect yourself.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.